| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442850 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
Angiosarcoma response and survival following first-line anthracycline-based chemotherapy was similar to other STS histotypes. Our analysis provides a useful measure of angiosarcoma response to chemotherapy for comparison with future clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
R.J. Young, A. Natukunda, S. Litière, P.J. Woll, E. Wardelmann, W.T.A. van der Graaf,